Genotype-driven recruitment: A strategy whose time has come?

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Budin Ljøsne, Isabelle ^a   Soye, Kaitlin J ^b   Tassé, Anne Marie ^b   Knoppers, Bartha Maria ^b   Harris, Jennifer R ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Biobanks; Feedback of results; Genetic testing; Genotype Driven Recruitment

Indexed keywords

ARTICLE; FOLLOW UP; GENETIC ANALYSIS; GENOTYPE; GENOTYPE DRIVEN RECRUITMENT; HEALTH CARE SYSTEM; MEDICAL INFORMATION; MEDICAL RECORD; METHODOLOGY; PRIORITY JOURNAL; RESEARCH ETHICS;

BIOLOGICAL SPECIMEN BANKS; ETHICS, RESEARCH; GENETIC TESTING; GENOTYPE; HUMANS; RESEARCH DESIGN;

EID: 84878005909     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-19     Document Type: Article

References (40)

1. Ethical challenges in genotype-driven research recruitment. Beskow LM, Linney KN, Radtke RA, Heinzen EL, Goldstein DB, Genome Res 2010 20 705 709 10.1101/gr.104455.109 20418491
2. Don't throw the baby out with the bathwater: enabling a bottom-up approach in genome-wide association studies. McGuire SE, McGuire AL, Genome Res 2008 18 1683 1685 10.1101/gr.083584.108 18974262
3. Research participants' perspectives on genotype-driven research recruitment. Beskow LM, Namey EE, Cadigan RJ, Brazg T, Crouch J, Henderson GE, Michie M, Nelson DK, Tabor HK, Wilfond BS, J Empir Res Hum Res Ethics 2011 6 3 20 22228056
4. Ethical issues in identifying and recruiting participants for familial genetic research. Beskow LM, Botkin JR, Daly M, Juengst ET, Lehmann LS, Merz JF, Pentz R, Press NA, Ross LF, Sugarman J, Am J Med Genet A 2004 130A 424 431 10.1002/ajmg.a.30234 15455364 (Pubitemid 39441623)
5. Offering individual genetic research results: context matters. Beskow LM, Burke W, Sci Transl Med 2010 2 38cm20 10.1126/scitranslmed.3000952 20592417
6. IRB chairs' perspectives on genotype-driven research recruitment. Beskow LM, Namey EE, Miller PR, Nelson DK, Cooper A, IRB 2012 34 1 10 23342734
7. Recommendations for ethical approaches to genotype-driven research recruitment. Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS, Hum Genet 2012 131 1423 1431 10.1007/s00439-012-1177-z 22622788
8. A review of ethical frameworks for the disclosure of individual research results in population-based genetic and genomic research. Budin-Ljøsne I, Research Ethics 2012 8 25 42 10.1177/1747016111435576
9. The meaning of genetic research results: reflections from individuals with and without a known genetic disorder. Cadigan RJ, Michie M, Henderson G, Davis AM, Beskow LM, J Empir Res Hum Res Ethics 2011 6 30 40 10.1525/jer.2011.6.4.30 22228058
10. Research ethics recommendations for whole-genome research: consensus statement. Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, PLoS Biol 2008 6 73 10.1371/journal.pbio.0060073 18366258 (Pubitemid 351492451)
11. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M, J Law Med Ethics 2012 40 1008 1024 23289702
12. Informed consent in genomics and genetic research. McGuire AL, Beskow LM, Annu Rev Genomics Hum Genet 2010 11 361 381 10.1146/annurev-genom-082509-141711 20477535
13. Personal genome research: what should the participant be told? McGuire AL, Lupski JR, Trends Genet 2010 26 199 201 10.1016/j.tig.2009.12.007 20381895
14. Am I a control? Genotype-driven research recruitment and self-understandings of study participants. Michie M, Cadigan RJ, Henderson G, Beskow LM, Genet Med 2012 14 983 989 10.1038/gim.2012.88 22935717
15. Epilepsy patient-participants and genetic research results as "answers" Namey EE, Beskow LM, J Empir Res Hum Res Ethics 2011 6 21 29 22228057
16. Exploring the ELSI universe: critical issues in the evolution of human genomic research. Oliver JM, McGuire AL, Genome Med 2011 3 38 10.1186/gm254 21699745
17. Parent perspectives on pediatric genetic research and implications for genotype-driven research recruitment. Tabor HK, Brazg T, Crouch J, Namey EE, Fullerton SM, Beskow LM, Wilfond BS, J Empir Res Hum Res Ethics 2011 6 41 52 10.1525/jer.2011.6.4.41 22228059
18. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Wolf SM, Crock BN, Van NB, Lawrenz F, Kahn JP, Beskow LM, Cho MK, Christman MF, Green RC, Hall R, Genet Med 2012 14 361 384 10.1038/gim.2012.23 22436882
19. National Research Council, Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease Washington, DC: The National Academies Press 2011
20. FarGen project [ http://cphx.org/2012/08/bogi-eliasen-sequencing-the- entire-nation-of-the-faroe-islands/ ]
21. Jakobsen RK, Sequencing the genome of an entire population [ http://sciencenordic.com/sequencing-genome-entire-population ]
22. Doward J, Plans for NHS database of patients' DNA angers privacy campaigners [ http://www.guardian.co.uk/politics/2012/dec/09/dna-database-nhs- gene-genomics ] 23587976
23. Human Genomics Strategy Group, Building on our inheritance-Genomic technology in health care [ https://www.gov.uk/government/uploads/system/ uploads/attachment-data/file/134568/dh-132382.pdf.pdf ]
24. Health Law Institute University of Alberta, Analysis of Privacy Policies and Practices of Direct-to-Consumer Genetic Testing Companies: Private Sector Databanks and Privacy Protection Norms [ http://www.heals.ualberta.ca/People/ ExternalResearchFellows/NolaMRies/∼/media/heals/ResearchDocuments/ OPCC-Report-March-28-2010.pdf ]
25. Vorhaus D, Moore L, What happens if a DTC genomics company goes belly up? [ http://www.genomicslawreport.com/index.php/2009/09/18/what-happens-if-a-dtc- genomics-company-goes-belly-up/ ]
26. 23anMe Research Portal Call for Academic Collaborators, [ https://www.23andme.com/researchportal/ ]
27. Obasogie OK, Googling Your Genes? [ http://www.biopoliticaltimes.org/ article.php?id=3536 ]
28. Shanks P, New Business Plans for the Direct-to-Consumer Gene Testing Industry? [ http://www.biopoliticaltimes.org/article.php?id=6552 ]
29. Thresholds and boundaries in the disclosure of individual genetic research results. Dressler LG, Juengst ET, Am J Bioeth 2006 6 18 20 17085396 (Pubitemid 44691475)
30. Obligations in offering to disclose genetic research results. Fernandez CV, Weijer C, Am J Bioeth 2006 6 44 46 17085409 (Pubitemid 44691488)
31. Disclosing individual results of clinical research: implications of respect for participants. Shalowitz DI, Miller FG, JAMA 2005 294 737 740 10.1001/jama.294.6.737 16091577 (Pubitemid 41159294)
32. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a national heart, lung, and blood institute working group. Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, Biesecker LG, Bookman E, Burke W, Burchard EG, Church G, Circ Cardiovasc Genet 2010 3 574 580 10.1161/CIRCGENETICS.110.958827 21156933
33. Return of "accurate" and "actionable" results: yes! Knoppers BM, Laberge C, Am J Bioeth 2009 9 107 109 10.1080/15265160902918788 19998141
34. Population studies: return of research results and incidental findings Policy Statement. Knoppers BM, Deschenes M, Zawati MH, Tasse AM, Eur J Hum Genet 2013 21 245 247 10.1038/ejhg.2012.152 22781095
35. Disclosure of APOE genotype for risk of Alzheimer's disease. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, N Engl J Med 2009 361 245 254 10.1056/NEJMoa0809578 19605829
36. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, Gruber SB, Cancer Epidemiol Biomarkers Prev 2011 20 522 529 10.1158/1055-9965.EPI-10-1045 21307304
37. Legislation on direct-to-consumer genetic testing in seven European countries. Borry P, van Hellemondt RE, Sprumont D, Jales CF, Rial-Sebbag E, Spranger TM, Curren L, Kaye J, Nys H, Howard H, Eur J Hum Genet 2012 20 715 721 10.1038/ejhg.2011.278 22274578
38. Vorhaus D, What five FDA letters mean for the future of DTC genetic testing? [ http://www.genomicslawreport.com/index.php/2010/06/11/what-five-fda- letters-mean-for-the-future-of-dtc-genetic-testing/ ]
39. Geneticization and bioethics: advancing debate and research. Arnason V, Hjorleifsson S, Med Health Care Philos 2007 10 417 431 10.1007/s11019-007-9088-9 17705026
40. Genetic exceptionalism. Too much of a good thing? Evans JP, Burke W, Genet Med 2008 10 500 501 10.1097/GIM.0b013e31817f280a 18580684